Clinical Trial Update: RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating RAD001 (everolimus) combined with temozolomide in advanced pancreatic neuroendocrine tumors; study status completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• RAD001 (everolimus)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Neuroendocrine Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-09